Dr. Sumanth Kumar Mallupattu
Verified Specialist

Dr. Sumanth Kumar Mallupattu

Senior Consultant — Medical Oncology

Medical Oncologist

CARE Hospitals Hyderabad, India 14+ Years Experience
4.9

320 verified reviews

320

Recent Consultations

About Dr. Sumanth Kumar Mallupattu

Dr. Sumanth Kumar Mallupattu is a Senior Consultant Medical Oncologist with over 14 years of clinical experience and a distinguished academic pedigree. He holds a DM in Medical Oncology from the prestigious Nizam's Institute of Medical Sciences (NIMS) and an MD in Radiation Oncology from Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, giving him a uniquely comprehensive understanding of cancer care across both medical and radiation oncology disciplines.

At CARE Hospitals in Hyderabad, Dr. Sumanth Kumar delivers evidence-based cancer treatment across a broad spectrum of malignancies. His clinical expertise encompasses chemotherapy, cancer immunotherapy, and targeted therapy for solid organ cancers including breast, thoracic, gastrointestinal, and urological malignancies. He is equally proficient in haematological oncology, managing lymphomas, leukaemias, multiple myeloma, and non-cancerous blood disorders such as anaemia, thrombocytopenia, and pancytopenia in both adult and pediatric patients. His approach combines the latest therapeutic innovations with personalized patient-centred care.

Dr. Sumanth Kumar regularly receives international patients from the Gulf region, Africa, and the Indian subcontinent. His fluency in English, Hindi, and Telugu, combined with his international training and membership in globally recognized organizations, makes him accessible to patients seeking second opinions or primary oncological treatment abroad. He ensures seamless communication and cultural sensitivity throughout the treatment journey.

CARE Hospitals Hyderabad is a Joint Commission International (JCI)-accredited facility with state-of-the-art oncology units, advanced diagnostic imaging, and dedicated haemato-oncology wards. The hospital's robust infrastructure, experienced support staff, and established international patient services make it an ideal destination for cancer care. International patients benefit from coordinated medical tourism support, transparent pricing, and comprehensive follow-up protocols. Dr. Sumanth Kumar's practice exemplifies the high standard of oncological care available in India, combining world-leading expertise with affordable, accessible treatment for patients worldwide.

Conditions Treated by Dr. Sumanth Kumar Mallupattu

  • Breast Cancer
  • Lung Cancer and Thoracic Malignancies
  • Gastrointestinal Cancers
  • Lymphoma
  • Leukaemia
  • Multiple Myeloma
  • Urological Cancers
  • Gynaecological Cancers
  • Anaemia
  • Thrombocytopenia
  • Pancytopenia
  • Polycythemia

Areas of Interest

  • Chemotherapy for Cancer
  • Cancer Immunotherapy
  • Targeted Therapy for Cancer
  • Hormone Therapy for Breast Cancer
  • Breast Cancer Management
  • Thoracic Malignancies
  • Gastrointestinal Cancers
  • Hematological Cancers

Qualifications

  • DMNizam's Institute of Medical Sciences (NIMS), 2019
  • MDPostgraduate Institute of Medical Education and Research (PGIMER), 2012
  • MBBSKurnool Medical College, 2005

Work Experience

  • Senior Consultant, Medical Oncology — CARE Hospitals, Hyderabad
  • Consultant, Haemato-Oncology — Yashoda Hospital, Secunderabad
  • Faculty and Consultant — Nizam's Institute of Medical Sciences (NIMS), Hyderabad
  • Consultant Oncologist — Indian Red Cross Society Cancer Hospital, Hyderabad
  • Consultant — MNJ Cancer Hospital, Osmania Medical College, Hyderabad
  • Training and Clinical Experience — Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry

Certifications (5)

  • DM in Medical Oncology

    Nizam's Institute of Medical Sciences (NIMS) — 2019

  • MD in Radiation Oncology

    Postgraduate Institute of Medical Education and Research (PGIMER) — 2012

  • MBBS

    Kurnool Medical College — 2005

  • Member, American Society of Clinical Oncology (ASCO)

    ASCO

  • Member, European Society for Medical Oncology (ESMO)

    ESMO

Memberships (4)

  • ASCO — American Society of Clinical Oncology
  • ESMO — European Society for Medical Oncology
  • ESTRO — European Society for Radiotherapy and Oncology
  • IAPC — Indian Association of Palliative Care

Research Papers & Publications (5)

Immunotherapy Response in Advanced Breast Cancer: A Prospective Indian Cohort Study

Indian Journal of Medical Oncology2021

Targeted Therapy Outcomes in Non-Small Cell Lung Cancer: A Single-Centre Experience

Lung Cancer International2020

Management of Haematological Malignancies in Paediatric and Adult Populations: Best Practice Review

Journal of Clinical Oncology Practice2019

Hormone Receptor Status and Treatment Planning in Metastatic Breast Cancer

Cancer Research and Therapy2018

Palliative Care Integration in Advanced Gastrointestinal Malignancies

Indian Journal of Palliative Care2017

Procedures

Chemotherapy for Solid Organ Cancers Cancer Immunotherapy (ICIs and CAR-T)Targeted Therapy and Molecular-Guided TreatmentHormone Therapy for Breast CancerManagement of Lymphomas and LeukaemiasMultiple Myeloma Treatment and Monitoring Palliative Oncology and Symptom ManagementHaematological Disorder Evaluation and Treatment

Frequently Asked Questions

International patients can schedule a consultation through Gaf Healthcare's patient coordination team via WhatsApp, email, or our online portal. We arrange video consultations at a time convenient for your timezone, allowing Dr. Sumanth to review your medical records and imaging before your first appointment. Our team assists with document translation, second-opinion reports, and coordinating your travel and hospital admission once a treatment plan is established.